The SEC has declared effective the registration statement for the business combination, setting the stage for Impact Biomedical's special meeting of stockholders on November 13, 2026, to approve the merger.
The SEC has declared effective the registration statement for the business combination, setting the stage for Impact Biomedical's special meeting of stockholders on November 13, 2026, to approve the merger.